Home Amines 474023-97-7
474023-97-7,MFCD23164182
Catalog No.:AA01KKMK

474023-97-7 | (S)-2-Amino-4-((tert-butyldimethylsilyl)oxy)butanoicacid

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
97%
in stock  
$12.00   $8.00
- +
250mg
97%
in stock  
$21.00   $15.00
- +
1g
97%
in stock  
$65.00   $46.00
- +
5g
97%
in stock  
$240.00   $168.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA01KKMK
Chemical Name:
(S)-2-Amino-4-((tert-butyldimethylsilyl)oxy)butanoicacid
CAS Number:
474023-97-7
Molecular Formula:
C10H23NO3Si
Molecular Weight:
233.3800
MDL Number:
MFCD23164182
SMILES:
N[C@H](C(=O)O)CCO[Si](C(C)(C)C)(C)C
Properties

Downstream Synthesis Route

[1]Arnaud,Ophélie;Koubeissi,Ali;Ettouati,Laurent;Terreux,Raphaël;Alamé,Ghina;Grenot,Catherine;Dumontet,Charles;DiPietro,Attilio;Paris,Joëlle;Falson,Pierre[JournalofMedicinalChemistry,2010,vol.53,#18,p.6720-6729]

[2]CurrentPatentAssignee:MACROPHAGEPHARMA-WO2006/117567,2006,A2Locationinpatent:Page/Pagecolumn39

[3]CurrentPatentAssignee:CHROMATHERAPEUTICSLIMITED-WO2007/129036,2007,A1Locationinpatent:Page/Pagecolumn30-31

[4]CurrentPatentAssignee:CHROMATHERAPEUTICSLIMITED-WO2008/50096,2008,A1Locationinpatent:Page/Pagecolumn24

[5]CurrentPatentAssignee:CHROMATHERAPEUTICSLIMITED-WO2008/56120,2008,A1Locationinpatent:Page/Pagecolumn60-61

[6]CurrentPatentAssignee:CHROMATHERAPEUTICSLIMITED-US2011/39920,2011,A1Locationinpatent:Page/Pagecolumn11

[7]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2006/117548,2006,A1Locationinpatent:Page/Pagecolumn37-38

[8]CurrentPatentAssignee:CHROMATHERAPEUTICSLIMITED-WO2006/117552,2006,A1Locationinpatent:Page/Pagecolumn27-28

[9]CurrentPatentAssignee:CHROMATHERAPEUTICSLIMITED-WO2009/130434,2009,A1Locationinpatent:Page/Pagecolumn22

[10]CurrentPatentAssignee:CHROMATHERAPEUTICSLIMITED-WO2007/129020,2007,A1Locationinpatent:Page/Pagecolumn21-22

[11]CurrentPatentAssignee:ZHEJIANGHISOARPHARMACEUTICALCO.,LTD.-EP2647624,2013,A1Locationinpatent:Paragraph0052

[12]CurrentPatentAssignee:UNIVERSITYHEALTHNETWORK-WO2017/27967,2017,A1Locationinpatent:Paragraph00125;00128;

[13]Tejeda,ElizabethJ.Curiel;Bello,AngelicaM.;Wasilewski,Ewa;Koebel,Adam;Dunn,Shannon;Kotra,LakshmiP.[JournalofMedicinalChemistry,2017,vol.60,#21,p.8876-8887]

[14]Koubeissi,Ali;Raad,Imad;Ettouati,Laurent;Guilet,David;Dumontet,Charles;Paris,Joelle[BioorganicandMedicinalChemistryLetters,2006,vol.16,#21,p.5700-5703]

[15]CurrentPatentAssignee:LAUNAYDELPHINEFRANCOISEMONI;CHROMATHERAPEUTICSLIMITED-WO2010/43867,2010,A1Locationinpatent:Page/Pagecolumn44-45

[16]Pan,Xianhua;Li,Xiaojun;Lu,Qingling;Yu,Wansheng;Li,Weijin;Zhang,Qunhui;Deng,Fei;Liu,Feng[TetrahedronLetters,2013,vol.54,#50,p.6807-6809]

[1]Patent:WO2006/117567,2006,A2.Locationinpatent:Page/Pagecolumn38

[2]Patent:WO2007/129036,2007,A1.Locationinpatent:Page/Pagecolumn31

[3]Patent:WO2008/50096,2008,A1.Locationinpatent:Page/Pagecolumn24

[4]Patent:WO2008/56120,2008,A1.Locationinpatent:Page/Pagecolumn60

[5]Patent:WO2010/43867,2010,A1.Locationinpatent:Page/Pagecolumn44

[6]Patent:US2011/39920,2011,A1.Locationinpatent:Page/Pagecolumn11

[7]Patent:WO2006/117548,2006,A1.Locationinpatent:Page/Pagecolumn37-38

[8]Patent:WO2006/117552,2006,A1.Locationinpatent:Page/Pagecolumn27

[9]Patent:WO2009/130434,2009,A1.Locationinpatent:Page/Pagecolumn21-22

[10]Patent:WO2007/129005,2007,A1.Locationinpatent:Page/Pagecolumn30-31

[11]Patent:WO2007/129020,2007,A1.Locationinpatent:Page/Pagecolumn21-22

[12]BioorganicandMedicinalChemistryLetters,2006,vol.16,p.5700-5703

[13]JournalofMedicinalChemistry,2010,vol.53,p.6720-6729

[14]Patent:WO2017/27967,2017,A1.Locationinpatent:Paragraph00125;00127

[15]JournalofMedicinalChemistry,2017,vol.60,p.8876-8887

[16]JournaloftheAmericanChemicalSociety,2011,vol.133,p.15866-15869

[17]JournalofMedicinalChemistry,2007,vol.50,p.6326-6336

[18]Patent:EP2647624,2013,A1.Locationinpatent:Paragraph0050;0051;0052

[19]Patent:US2013/281695,2013,A1.Locationinpatent:Paragraph0096-0099

[20]TetrahedronLetters,2013,vol.54,p.6807-6809

[1]CurrentPatentAssignee:CHROMATHERAPEUTICSLIMITED-WO2007/129005,2007,A1Locationinpatent:Page/Pagecolumn30-31

[1]Koubeissi,Ali;Raad,Imad;Ettouati,Laurent;Guilet,David;Dumontet,Charles;Paris,Joelle[BioorganicandMedicinalChemistryLetters,2006,vol.16,#21,p.5700-5703]

[1]Koubeissi,Ali;Raad,Imad;Ettouati,Laurent;Guilet,David;Dumontet,Charles;Paris,Joelle[BioorganicandMedicinalChemistryLetters,2006,vol.16,#21,p.5700-5703]

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 474023-97-7
Building Blocks
More >
Tags:474023-97-7 Molecular Formula|474023-97-7 MDL|474023-97-7 SMILES|474023-97-7 (S)-2-Amino-4-((tert-butyldimethylsilyl)oxy)butanoicacid